Diabetes Drugs: Alpha-Glucosidase Inhibitors :: Diabetes Self-Management
Links shared publicly online about this topic.
- 1,763total visits
Diabetes Drugs: Alpha-Glucosidase Inhibitors :: Diabetes Self-Management
View full resource at diabetesselfmanagement.com
Tags: Diabetes, Diabetes Medication, Hyperglycemia Medication, Carbohydrate, Drug, Basen
Most Recently Shared on September 8, 2009 at 8:29 pm By:
#diabetes Alpha-glucosidase inhibitors take the spotlight in Mark Marino's miniseries on diabetes drugs. http://bit.ly/11E8Nj
A List of Oral Medications for Diabetes 2 Treatment -- Part 3 | The Diabetes Club
thediabetesclub.com — “Part 1 -- Part 2 -- Part 3 Alpha-glucosidase inhibitors are the third type of pills available to treat type 2 diabetes. There are only two medications” View full resource at thediabetesclub.com
Most Recently Shared on November 3, 2010 at 6:33 pm By:
EmiliaK Nutritionist and Dietitian
Oral medications for diabetes 2 treatment and its side effects http://ow.ly/33WhY www.TheDiabetesClub.com
Diabetes prevention: Meta-analysis finds glitazones superior to other oral antidiabetic drug classes - - Drug Topics
drugtopics.modernmedicine.com — “A systematic review assessing the comparative effectiveness of oral anti-diabetic drugs for preventing patients at high risk from progressing to type 2 diabetes has found glitazones (pioglitazone, rosiglitazone), biguanides (metformin), and alpha-glucosidase inhibitors (AGIs; acarbose, voglibose) reduced the relative risk of diabetes by as much as 63%, whereas insulin secretagogues (sulfonylureas and glinides) had no effect.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on July 6, 2010 at 9:00 am By:
Diabetes prevention: Meta-analysis finds glitazones superior to other oral antidiabetic drug classes: A systematic... http://bit.ly/9E7NMw
Diabetes Drugs: DPP-4 Inhibitors :: Diabetes Self-Management
diabetesselfmanagement.com — “Dpp-4 inhibitors, a relatively new class of drugs for type 2 diabetes, were introduced in 2006. sitagliptin (brand name januvia), the first medicine in this class, was approved for the treatment of type 2 diabetes in october 2006; in july 2009, a second dpp-4 inhibitor, saxagliptin (onglyza), was approved...” View full resource at diabetesselfmanagement.com
Most Recently Shared on October 2, 2009 at 8:06 pm By:
Diabetes Self-Mgmt Health Site
#diabetes The science behind this drug class has been developing for over 100 years. Learn more about it. http://bit.ly/LNDUp
New Diabetes Drug Approved :: Diabetes Self-Management
diabetesselfmanagement.com — “On july 31, the u.s. food and drug administration (fda) approved the oral diabetes medicine saxagliptin (brand name onglyza), a joint development of bristol-myers squibb and astrazeneca. onglyza will join januvia as a member of the class of drugs known as dpp-4 inhibitors...” View full resource at diabetesselfmanagement.com
Most Recently Shared on August 14, 2009 at 8:51 pm By:
Diabetes Self-Mgmt Health Site
#diabetes New Blog post by Diane Fennell: New Diabetes Drug Approved http://bit.ly/L5QBc
DPP-4 Inhibitors :: Diabetes Self-Management
diabetesselfmanagement.com — “In 2006, a new class of medicine for Type 2 diabetes was introduced to the U.S. market. Called DPP-4 inhibitors, these drugs work in a way that is different from any previous diabetes treatment. Sitagliptin (brand name Januvia) is the first drug in this class to be approved; it can be used alone or in combination with other oral diabetes drugs. Saxagliptin (Onglyza), another DPP-4 inhibitor, received approval in August 2009...” View full resource at diabetesselfmanagement.com
Most Recently Shared on August 12, 2009 at 7:05 pm By:
Diabetes Self-Mgmt Health Site
#diabetes Article of the Week: DPP-4 Inhibitors: A Novel Class of Drugs for Type 2 Diabetes http://bit.ly/19Q8o8
Advertisement
